Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-19-000090
Filing Date
2019-11-12
Accepted
2019-11-12 16:24:48
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sesn-09302019x10q.htm 10-Q 883932
2 EXHIBIT 10.1 sesn-09302019x10qex101.htm EX-10.1 52731
3 EXHIBIT 10.3 sesn-09302019x10qex103.htm EX-10.3 51659
4 EXHIBIT 31.1 sesn-09302019x10qex311.htm EX-31.1 14839
5 EXHIBIT 31.2 sesn-09302019x10qex312.htm EX-31.2 14765
6 EXHIBIT 32.1 sesn-09302019x10qex321.htm EX-32.1 8231
7 EXHIBIT 32.2 sesn-09302019x10qex322.htm EX-32.2 8221
  Complete submission text file 0001485003-19-000090.txt   4984058

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sesn-20190930.xml EX-101.INS 880700
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20190930.xsd EX-101.SCH 41648
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20190930_cal.xml EX-101.CAL 56241
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20190930_def.xml EX-101.DEF 172238
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20190930_lab.xml EX-101.LAB 536638
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20190930_pre.xml EX-101.PRE 316908
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 191209892
SIC: 2834 Pharmaceutical Preparations